
    
      a 48-week, double blind, randomized, multinational, multicentre, 2-arm parallel group,
      reference treatment controlled clinical trial of "fixed combination" beclomethasone
      dipropionate plus formoterol fumarate versus formoterol in patients with severe chronic
      obstructive pulmonary disease
    
  